Skip to main content
. 2007 Jul;9(3):335–342. doi: 10.1215/15228517-2007-013

Table 3.

Clinical parameters and associations between presence and absence of thrombocytosis in all operated patients with subsequent radiation therapy with or without additional chemotherapy

Parameter < 400 Platelets/nl (n = 87) > 400 Platelets/nl (n = 11) Test PValue
Age (years) 63.3 ± 11.1 (n =87) 65.8 ± 6.4 (n = 11) t-test 0.4620
KPSa 80 (50–100; n =86) 80 (50–90; n =11) Mann-Whitney test 0.6618
Tumor volume (ml) 23.5 ± 20.3 (n =37) 48.7 ± 23.1 (n =4) t-test 0.0248
Platelet count (per nl) 275 ± 65 (n =87) 440 ± 42 (n =11) t-test < 0.0001
Hemoglobin (g/100 ml) 14.5 ± 1.4 (n = 87) 14.2 ± 1.7 (n = 11) t-test 0.6376
aPTT (s) 23.2 ± 2.9 (n = 81) 24.4 ± 2.7 (n = 10) t-test 0.2069
Prothrombin time (%) 99.8 ± 11.0 (n =86) 97.5 ± 13.4 (n =11) t-test 0.5382
Fibrinogen (g/l) 2.7 ± 1.0 (n = 51) 3.2 ± 1.5 (n = 7) t-test 0.4248
Smokers 12 (15%) 3 (30%) Fisher’s exact test 0.3610
Nonsmokers 68 (85%) 7 (70%)
Female 36 (41.4%) 5 (45.5%) Fisher’s exact test 1.0000
Male 51 (58.6%) 6 (54.5%)
Incomplete resection 20 (23.0%) 3 (27.3%) Fisher’s exact test 0.7164
Complete resection 67 (77.0%) 8 (72.7%)
RT only 43 (49.4%) 4 (36.4%) Chi-square test 0.4139
RT and CT 44 (50.6%) 7 (63.6%)

Abbreviations: aPTT, activated partial thromboplastin time; RT, radiation therapy, CT, chemotherapy. Nonoperated patients or operated patients without subsequent RT were excluded from this analysis. All quantitative parameters are given as mean ± 1 SD or number of patients (%); KPS is given as median and range; the qualitative parameters are expressed in frequencies.